Traws Pharma, Inc. (TRAW)
0.409
-0.01
(-1.68%)
USD |
NASDAQ |
Oct 13, 10:19
Traws Pharma EPS Diluted (Quarterly) : -0.1924 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1924 |
| March 31, 2026 | -0.6675 |
| December 31, 2025 | -1.000 |
| September 30, 2025 | -0.4489 |
| June 30, 2025 | -0.157 |
| March 31, 2025 | 2.975 |
| December 31, 2024 | -8.180 |
| September 30, 2024 | -8.707 |
| June 30, 2024 | -121.63 |
| March 31, 2024 | -5.92 |
| December 31, 2023 | -4.980 |
| September 30, 2023 | -5.641 |
| June 30, 2023 | -5.064 |
| March 31, 2023 | -6.888 |
| December 31, 2022 | -6.475 |
| September 30, 2022 | -6.452 |
| June 30, 2022 | -4.812 |
| March 31, 2022 | -4.930 |
| December 31, 2021 | -4.503 |
| September 30, 2021 | -5.402 |
| June 30, 2021 | -6.703 |
| March 31, 2021 | -8.066 |
| December 31, 2020 | -12.97 |
| September 30, 2020 | -12.94 |
| June 30, 2020 | -16.35 |
| Date | Value |
|---|---|
| March 31, 2020 | -11.91 |
| December 31, 2019 | -19.39 |
| September 30, 2019 | -280.55 |
| June 30, 2019 | -224.49 |
| March 31, 2019 | -483.86 |
| December 31, 2018 | -373.47 |
| September 30, 2018 | -353.44 |
| June 30, 2018 | -413.10 |
| March 31, 2018 | -1891.29 |
| December 31, 2017 | -3293.04 |
| September 30, 2017 | -3974.74 |
| June 30, 2017 | -1615.16 |
| March 31, 2017 | -6928.88 |
| December 31, 2016 | -4532.51 |
| September 30, 2016 | -1631.25 |
| June 30, 2016 | -11025.00 |
| March 31, 2016 | -15187.50 |
| December 31, 2015 | 7050.94 |
| September 30, 2015 | -14625.00 |
| June 30, 2015 | -23062.50 |
| March 31, 2015 | -32062.50 |
| December 31, 2014 | -34875.00 |
| September 30, 2014 | -38812.50 |
| June 30, 2014 | -43312.50 |
| March 31, 2014 | -48937.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.054M |
| Total Expenses (Quarterly) | 3.054M |
| Enterprise Value | 1.337M |
| Earnings Yield | -564.6% |
| Normalized Earnings Yield | -562.30 |